Clinical utility of circulating Epstein-Barr virus DNA analysis for the management of nasopharyngeal carcinoma

2016 ◽  
Vol 5 (2) ◽  
pp. 18-18 ◽  
Author(s):  
Sherwood Y. H. Fung ◽  
Jacky W. K. Lam ◽  
Kwan Chee Allen Chan
Keyword(s):  
Nasopharyngeal Carcinoma ◽  
Clinical Utility ◽  
Epstein Barr Virus ◽  
Dna Analysis ◽  
Barr Virus ◽  
Epstein Barr

scholarly journals Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program

Cancer ◽  
2013 ◽  
Vol 119 (10) ◽  
pp. 1838-1844 ◽  
Author(s):  
K. C. Allen Chan ◽  
Emily C. W. Hung ◽  
John K. S. Woo ◽  
Paul K. S. Chan ◽  
Sing-Fai Leung ◽  
...  
Keyword(s):  
Nasopharyngeal Carcinoma ◽  
Early Detection ◽  
Epstein Barr Virus ◽  
Dna Analysis ◽  
Surveillance Program ◽  
Barr Virus ◽  
Epstein Barr

scholarly journals Clinical utility of plasma Epstein-Barr virus DNA andERCC1single nucleotide polymorphism in nasopharyngeal carcinoma

Cancer ◽  
2015 ◽  
Vol 121 (16) ◽  
pp. 2720-2729 ◽  
Author(s):  
Edwin P. Hui ◽  
Brigette B. Y. Ma ◽  
K. C. Allen Chan ◽  
Charles M. L. Chan ◽  
Cesar S. C. Wong ◽  
...  
Keyword(s):  
Nasopharyngeal Carcinoma ◽  
Clinical Utility ◽  
Epstein Barr Virus ◽  
Nucleotide Polymorphism ◽  
Barr Virus ◽  
Epstein Barr

Clinical Utility of Epstein-Barr Virus DNA Testing in the Treatment of Nasopharyngeal Carcinoma Patients

2017 ◽  
Vol 98 (5) ◽  
pp. 996-1001 ◽  
Author(s):  
Kelly Y. Kim ◽  
Quynh-Thu Le ◽  
Sue S. Yom ◽  
Raymond H.W. Ng ◽  
K.C. Allen Chan ◽  
...  
Keyword(s):  
Nasopharyngeal Carcinoma ◽  
Clinical Utility ◽  
Epstein Barr Virus ◽  
Dna Testing ◽  
Barr Virus ◽  
Epstein Barr

scholarly journals Clinical utility of Epstein‐Barr virus DNA and other liquid biopsy markers in nasopharyngeal carcinoma

2020 ◽  
Vol 40 (11) ◽  
pp. 564-585
Author(s):  
Rong Tan ◽  
Sean Kean Ann Phua ◽  
Yoke Lim Soong ◽  
Lynette Lin Ean Oon ◽  
Kian Sing Chan ◽  
...  
Keyword(s):  
Nasopharyngeal Carcinoma ◽  
Liquid Biopsy ◽  
Clinical Utility ◽  
Epstein Barr Virus ◽  
Barr Virus ◽  
Epstein Barr

scholarly journals The Clinical Utility of Plasma Epstein–Barr Virus DNA Assays in Nasopharyngeal Carcinoma

Medicine ◽  
2015 ◽  
Vol 94 (20) ◽  
pp. e845 ◽  
Author(s):  
Wenna Zhang ◽  
Yupei Chen ◽  
Lei Chen ◽  
Rui Guo ◽  
Guanqun Zhou ◽  
...  
Keyword(s):  
Nasopharyngeal Carcinoma ◽  
Clinical Utility ◽  
Epstein Barr Virus ◽  
Barr Virus ◽  
Dna Assays ◽  
Epstein Barr

Studies of Epstein-Barr Virus Antigens Using Immunoperoxidase and Immunofluorescence Techniques

1975 ◽  
Vol 33 ◽  
pp. 342-343
Author(s):  
R. Stephens ◽  
K. Traul ◽  
D. Woolf ◽  
P. Gaudreau
Keyword(s):  
Electron Microscopy ◽  
Nasopharyngeal Carcinoma ◽  
Epstein Barr Virus ◽  
Barr Virus ◽  
If Technique ◽  
Infected Cells ◽  
Virus Antigens ◽  
Epstein Barr ◽  
Virus Capsid Antigen ◽  
Antigen Reactivity

A number of antigens have been found associated with persistent EBV infections of lymphoblastoid cells. Identification and localization of these antigens were principally by immunofluorescence (IF) techniques using sera from patients with nasopharyngeal carcinoma (NPC), Burkitt lymphoma (BL), and infectious mononucleosis (IM). Our study was mainly with three of the EBV related antigens, a) virus capsid antigen (VCA), b) membrane antigen (MA), and c) early antigens (EA) using immunoperoxidase (IP) techniques with electron microscopy (EM) to elucidate the sites of reactivity with EBV and EBV infected cells.Prior to labeling with horseradish peroxidase (HRP), sera from NPC, IM, and BL cases were characterized for various reactivities by the indirect IF technique. Modifications of the direct IP procedure described by Shabo and the indirect IP procedure of Leduc were made to enhance penetration of the cells and preservation of antigen reactivity.

Sign in / Sign up

Export Citation Format

Share Document